www.nejm.org/doi/full/10.1056/NEJMoa1504627?fromsource=nelm& - t=articleTop
May 31, 2015 ... Julie Brahmer, M.D., Karen L. Reckamp, M.D., Paul Baas, M.D., Lucio ... (Funded
by Bristol-Myers Squibb; CheckMate 017 ClinicalTrials.gov ...
Julie A. Lemm, <sup>corresponding author</sup> ... BMS-791325 is an allosteric inhibitor that
binds to thumb site 1 of the hepatitis C virus (HCV) NS5B RNA-dependent RNA
polymerase. .... were synthesized by Bristol-Myers Squibb, as were HCV
reference inhibitors ..... Substitutions at NS5B codon 495 were also seen by
Pelosi et al.
Knowler et al. found that in the DPP, session attendance was associated with
older age, which may have contributed to long-term weight loss success. ...
Bristol-Myers Squibb and Parke-Davis provided additional funding and .... Julie
Bamdad, MS .... Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD
, Vijay V.
Aug 31, 2015 ... ... MD, University of California, Davis, Comprehensive Cancer Center, 4501 X St,
... DFS favored erlotinib (median, 46.4 v 28.5 months; hazard ratio, 0.61; 95% CI,
..... Boehringer Ingelheim, Merck, Merck Serono, Bristol-Myers Squibb, ... Julie D.
Horan ... Strauss GM,; Herndon JE 2nd,; Maddaus MA,; et al.
Jun 16, 2015 ... al nature of these associations using Mendelian randomization (MR). Methods
and Findings ..... Pharma AG, Bristol-Myers Squibb, Eisai Global.
Carrasquillo, M.M. et al. ..... Department of Neurology, University of Alabama at
Birmingham, Birmingham, ... Jeffrey L Cummings,; John M Ringman &; Harry V
Vinters ... Laboratory Medicine, University of California Davis, Sacramento,
California, .... Inc. M.R.F. receives research funding from Bristol-Myers Squibb
Jul 13, 2015 ... Cilag, and Bristol-Myers Squibb and speaker's fees from ... activation in the
ventral striatum (VS) during reward anticipation. ... reduced ethanol sensitivity in
ics mutants was not caused by al- ... Ojelade et al. ...... McGuire SE, Le PT,
Osborn AJ, Matsumoto K, Davis RL (2003) Spatiotemporal rescue of.
Mar 25, 2014 ... Correspondence to Dr Julie Rask Larsen; firstname.lastname@example.org .... In a study by
Astrup et al,7 16 of 90 patients (17.8%) in the liraglutide 1.8 mg group withdrew
over the 20-week trial period. .... as well as grants from Bristol-Myers Squibb,
Janssen/J&J and Otsuka. .... Hermes E,; Nasrallah H,; Davis V,; et al.
Sep 10, 2012 ... Editorial assistance was provided by Julie Taylor (funded by GlaxoSmithKline).
.... 21; Z.A. Fayad, V. Mani, M. Woodward, et al. ... Drs. Sarov-Blat, Cai, Lepore,
Davis, Willette, and Sprecher are employees ... Dr. Tawakol has received
research grants from Bristol-Myers Squibb, GlaxoSmithKline, Merck & Co.
Nov 18, 2013 ... B, Subjects on ABC/3TC, comparing women vs men. ..... We also thank Abbott
Laboratories, Bristol-Myers Squibb, Gilead Inc, and GlaxoSmithKline for
providing ... Richard B. Pollard, MD, and Abimbola Olusanya, NP, University of
California, Davis Medical Center ... Thompson MA,; Aberg JA,; Hoy JF,; et al.